Potiga (poe-TEE-ga, ezogabine), a new antiepileptic for partial onset seizures

Please see the October 2013 FDA Drug Safety Communication regarding Potiga and skin discoloration/retinal abnormalities

You'll see patients on Potiga (poe-TEE-ga, ezogabine), a new antiepileptic for partial onset seizures.

It has a unique mechanism...and some unusual side effects.

In fact, FDA will require a REMS risk management program to alert patients and prescribers to the risk of urinary retention.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote